pomalidomide NDC 72205-178

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-178Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0178Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72205-178-21	72205017821	21 CAPSULE in 1 BOTTLE, PLASTIC (72205-178-21)Marketed from Sep 2, 2026
72205-178-91	72205017891	100 CAPSULE in 1 BOTTLE, PLASTIC (72205-178-91)Marketed from Sep 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): pomalidomide
Generic name (nonproprietary): pomalidomide
Active ingredients: Pomalidomide — 3 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Novadoz Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210245
Marketing start: Sep 2, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 72205-178_b8c3b7f3-7e72-47af-be23-133e7bb3db59SPL ID b8c3b7f3-7e72-47af-be23-133e7bb3db59
Pharmacologic class: Thalidomide Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205017821 followed by a unit qualifier and the quantity

Package 72205-0178-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 210245

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210245
Product	Strength	Form · route	Labeler	Product NDC
pomalidomide	Pomalidomide 2 mg/1	CapsuleOral	Novadoz Pharmaceuticals LLC	72205-177
pomalidomide	Pomalidomide 4 mg/1	CapsuleOral	Novadoz Pharmaceuticals LLC	72205-179